AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Cecchi, A Di Marco, R
Citation: A. Cecchi et R. Di Marco, Homogenization of FRP pultruded elements: a computational procedure for designing composite materials, MATER STRUC, 34(240), 2001, pp. 378-384

Authors: Di Marco, R Puglisi, G Papaccio, G Nicoletti, A Patti, F Reggio, A Bendtzen, K Nicoletti, F
Citation: R. Di Marco et al., Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat, MULT SCLER, 7(2), 2001, pp. 101-104

Authors: Di Marco, R Khademi, M Wallstrom, E Iacobaeus, E Salvaggio, A Caracappa, S Papoian, R Nicoletti, F Olsson, T
Citation: R. Di Marco et al., Curative effects of recombinant human interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis, J NEUROIMM, 116(2), 2001, pp. 168-177

Authors: Nicoletti, F Di Marco, R Sacerdote, P Meroni, P Mangano, K Edwards, C Bartorelli, A Bendtzen, K Panerai, A
Citation: F. Nicoletti et al., Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14, ANTIM AG CH, 45(5), 2001, pp. 1591-1594

Authors: Nicoletti, F Di Marco, R Mangano, K Patti, F Reggio, E Nicoletti, A Bendtzen, K Reggio, A
Citation: F. Nicoletti et al., Increased serum levels of interleukin-18 in patients with multiple sclerosis, NEUROLOGY, 57(2), 2001, pp. 342-344

Authors: Nicoletti, F Conget, I Di Marco, R Speciale, AM Moringo, R Bendtzen, K Gomis, R
Citation: F. Nicoletti et al., Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes, DIABETOLOG, 44(3), 2001, pp. 309-311

Authors: Nicoletti, F Di Marco, R Patti, F Zaccone, P L'Episcopo, MR Reggio, E Xiang, M Nicoletti, A Reggio, A
Citation: F. Nicoletti et al., Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)beta 1b transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1 beta, IL-2, IL-4 and tumour necrosis factor-alpha, CYTOKINE, 12(6), 2000, pp. 682-687

Authors: Nicoletti, F Zaccone, P Xiang, M Magro, G Di Mauro, M Di Marco, R Garotta, G Meroni, P
Citation: F. Nicoletti et al., Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: Exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein, CYTOKINE, 12(4), 2000, pp. 315-323

Authors: Cecchi, A Di Marco, R
Citation: A. Cecchi et R. Di Marco, Homogenization of masonry walls with a computational oriented procedure. Rigid or elastic block?, EUR J MEC A, 19(3), 2000, pp. 535-546

Authors: Malaguarnera, L Pilastro, MR Vicari, L Di Marco, R Malaguarnera, M Messina, A
Citation: L. Malaguarnera et al., PTX3 gene expression in Castleman's disease, EUR J HAEMA, 64(2), 2000, pp. 132-134

Authors: Nicoletti, F Di Marco, R Conget, I Gomis, R Edwards, C Papaccio, G Bendtzen, K Sandler, S
Citation: F. Nicoletti et al., Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin, J AUTOIMMUN, 15(4), 2000, pp. 395-405

Authors: Nicoletti, F Di Marco, R Patti, F Nicoletti, A Leonardi, C Reggio, E Meroni, P Reggio, A
Citation: F. Nicoletti et al., The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta 1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells, AUTOIMMUN, 32(4), 2000, pp. 265-270

Authors: Nicoletti, F Di Marco, R Zaccone, P Salvaggio, A Magro, G Bendtzen, K Meroni, P
Citation: F. Nicoletti et al., Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism, HEPATOLOGY, 32(4), 2000, pp. 728-733

Authors: Khademi, M Wallstrom, E Andersson, M Piehl, F Di Marco, R Olsson, T
Citation: M. Khademi et al., Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis, J NEUROIMM, 103(2), 2000, pp. 202-210

Authors: Nicoletti, F Di Marco, R Zaccone, P Xiang, M Magro, G Grasso, S Morrone, S Santoni, A Shoenfeld, Y Garotta, G Meroni, P
Citation: F. Nicoletti et al., Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice, EUR J IMMUN, 30(2), 2000, pp. 438-447

Authors: Malaguarnera, L Pilastro, MR Vicari, L Di Marco, R Malaguarnera, M Messina, A
Citation: L. Malaguarnera et al., Ornithine decarboxylase gene expression in Castleman's disease, J MOL MED-J, 77(11), 1999, pp. 798-803

Authors: Di Marco, R Khademi, M Wallstrom, E Muhallab, S Nicoletti, F Olsson, T
Citation: R. Di Marco et al., Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10, J AUTOIMMUN, 13(2), 1999, pp. 187-195

Authors: Di Marco, R Xiang, M Zaccone, P Leonardi, C Franco, S Meroni, P Nicoletti, F
Citation: R. Di Marco et al., Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency, AUTOIMMUN, 31(2), 1999, pp. 75-83

Authors: Xiang, M Zaccone, P Di Marco, R Harris, R Magro, G Di Mauro, M Meroni, PL Garotta, G Nicoletti, F
Citation: M. Xiang et al., Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice, AUTOIMMUN, 30(2), 1999, pp. 71-80

Authors: Malaguarnera, M Restuccia, S Di Fazio, I Di Marco, R Pistone, G Trovato, BA
Citation: M. Malaguarnera et al., Rapid evolution of chronic viral hepatitis into hepatocellular carcinoma after beta-interferon treatment, PANMIN MED, 41(1), 1999, pp. 59-61

Authors: Nicoletti, F Di Marco, R Zaccone, P Magro, G Di Mauro, M Grasso, S Meroni, PL
Citation: F. Nicoletti et al., Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease, IMMUNOLOGY, 97(3), 1999, pp. 367-370

Authors: Xiang, M Zaccone, P Di Marco, R Magro, G Di Mauro, M Beltrami, B Meroni, PL Nicoletti, F
Citation: M. Xiang et al., Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice, EUR J PHARM, 367(2-3), 1999, pp. 399-404
Risultati: 1-22 |